Follow
Harry Harvey
Harry Harvey
Clinical Fellow, Princess Margaret Cancer Centre, Toronto
Verified email at tcd.ie
Title
Cited by
Cited by
Year
Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles
A Tivnan, WS Orr, V Gubala, R Nooney, DE Williams, C McDonagh, ...
PloS one 7 (5), e38129, 2012
2612012
Estrogen reduces lipid content in the liver exclusively from membrane receptor signaling
A Pedram, M Razandi, F O’Mahony, H Harvey, BJ Harvey, ER Levin
Science signaling 6 (276), ra36-ra36, 2013
1222013
Sexual dimorphism in colon cancer
M Abancens, V Bustos, H Harvey, J McBryan, BJ Harvey
Frontiers in Oncology 10, 607909, 2020
1192020
The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro
O Piskareva, H Harvey, J Nolan, R Conlon, L Alcock, P Buckley, ...
Cancer letters 364 (2), 142-155, 2015
922015
MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1
L Creevey, J Ryan, H Harvey, IM Bray, M Meehan, AR Khan, RL Stallings
Molecular cancer 12, 1-12, 2013
892013
Bidirectional KCNQ1: β-catenin interaction drives colorectal cancer cell differentiation
R Rapetti-Mauss, V Bustos, W Thomas, J McBryan, H Harvey, N Lajczak, ...
Proceedings of the National Academy of Sciences 114 (16), 4159-4164, 2017
732017
A physiologically relevant 3D collagen-based scaffold–neuroblastoma cell system exhibits chemosensitivity similar to orthotopic xenograft models
C Curtin, JC Nolan, R Conlon, L Deneweth, C Gallagher, YJ Tan, ...
Acta biomaterialia 70, 84-97, 2018
562018
Modulation of chemotherapeutic drug resistance in neuroblastoma SK‐N‐AS cells by the neural apoptosis inhibitory protein and mi R‐520f
H Harvey, O Piskareva, L Creevey, LC Alcock, PG Buckley, MJ O'Sullivan, ...
International journal of cancer 136 (7), 1579-1588, 2015
562015
GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions
V Bustos, ÁM Nolan, A Nijhuis, H Harvey, A Parker, R Poulsom, ...
Oncotarget 8 (48), 84258, 2017
492017
Cost implications of reactive versus prospective testing for dihydropyrimidine dehydrogenase deficiency in patients with colorectal cancer: a single-institution experience
C Murphy, S Byrne, G Ahmed, A Kenny, J Gallagher, H Harvey, ...
Dose-Response 16 (4), 1559325818803042, 2018
472018
The impact of a national cyberattack affecting clinical trials: the cancer trials Ireland experience
H Harvey, H Carroll, V Murphy, J Ballot, M O'Grady, D O'Hare, G Lawler, ...
JCO Clinical Cancer Informatics 7, e2200149, 2023
52023
The impact of a ransomware cyber attack on a breast cancer center.
H Harvey, R Joyce, K Rock, TJ Browne, MW Bennett, F O'Connell, ...
Journal of Clinical Oncology 40 (16_suppl), e13620-e13620, 2022
22022
Impact of Conti ransomware attack on cancer trials Ireland sites.
H Harvey, V Amberger-Murphy, J Ballot, M O'Grady, D O'Hare, G Lawler, ...
Journal of Clinical Oncology 40 (16_suppl), e13614-e13614, 2022
12022
Corrigendum to “The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro”[Cancer Lett 364 (2015) 142–155]
O Piskareva, H Harvey, J Nolan, R Conlon, L Alcock, P Buckley, ...
Cancer Letters 2 (369), 428, 2015
12015
Functional analysis of miRNA in chemotherapy resistant neuroblastoma
HM Harvey, IM Bray, RL Stallings
Cancer Research 72 (8_Supplement), 816-816, 2012
12012
Dealing with digital paralysis: Surviving a cyberattack in a National Cancer center
RJ Keogh, H Harvey, C Brady, E Hassett, SJ Costelloe, MJ O’Sullivan, ...
Journal of Cancer Policy 39, 100466, 2024
2024
Sex Differences in Colon Cancer: Genomic and Nongenomic Signalling of Oestrogen
BJ Harvey, HM Harvey
Genes 14 (12), 2225, 2023
2023
1730P Dealing with digital paralysis: Surviving a cyberattack in a cancer centre
RJ Keogh, HM Harvey, C Brady, E Hassett, SJ Costelloe, MJ O’Sullivan, ...
Annals of Oncology 34, S941, 2023
2023
The development of cisplatin resistance in neuroblastoma is
O Piskareva, H Harvey, J Nolan, R Conlon, L Alcock
cancer 71, 479-492, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–19